Suchergebnisse - "Sato, Shuntaro"

PubPharm (218)

31

Association between hospital acquired disability and post-discharge mortality in patients after living donor liver transplantation

enthalten in: BMC surgery | 2022

von Hanada, M. | Hidaka, M. | Soyama, A. | +13

32

Inhibition of bone erosion, determined by high-resolution peripheral quantitative computed tomography (HR-pQCT), in rheumatoid arthritis patients receiving a conventional synthetic disease-modifying anti-rheumatic drug (csDMARD) plus denosumab vs csDMARD therapy alone : an open-label, randomized, parallel-group study

enthalten in: Arthritis research & therapy | 2022

von Iwamoto, N. | Chiba, K. | Sato, S. | +15

33

Inhibition of bone erosion, determined by high-resolution peripheral quantitative computed tomography (HR-pQCT), in rheumatoid arthritis patients receiving a conventional synthetic disease-modifying anti-rheumatic drug (csDMARD) plus denosumab vs csDMARD therapy alone: an open-label, randomized, parallel-group study

enthalten in: Arthritis Research & Therapy | 2022

von Iwamoto, N. | Chiba, K. | Sato, S. | +15

34

Inhibition of bone erosion, determined by high-resolution peripheral quantitative computed tomography (HR-pQCT), in rheumatoid arthritis patients receiving a conventional synthetic disease-modifying anti-rheumatic drug (csDMARD) plus denosumab vs csDMARD therapy alone: an open-label, randomized, parallel-group study

enthalten in: Arthritis Research & Therapy | 2022

von Iwamoto, N. | Chiba, K. | Sato, S. | +15

35

The clinical advantage of nasal high-flow in respiratory management during procedural sedation : A scoping review on the application of nasal high-flow during dental procedures with sedation

enthalten in: The Japanese dental science review | 2022

von Kurata, S. | Sanuki, T. | Higuchi, H. | +7

36

Risk stratification of patients with cardiac sarcoidosis : the ILLUMINATE-CS registry

enthalten in: European heart journal | 2022

von Nabeta, T. | Kitai, T. | Naruse, Y. | +10

CommentIn: Eur Heart J. 2022 Aug 03;:. - PMID 35920166

37

A randomised, double-blind, placebo-controlled phase III trial on the efficacy and safety of tocilizumab in patients with familial Mediterranean fever

enthalten in: Clinical and experimental rheumatology | 2022

von Koga, T. | Sato, S. | Hagimori, N. | +10

38

Corrigendum to "Randomized controlled trial of daily teriparatide, weekly high-dose teriparatide, or bisphosphonate in patients with postmenopausal osteoporosis : The TERABIT study" [Bone 160 (2022) 116416

enthalten in: Bone | 2022

von Chiba, K. | Okazaki, N. | Kurogi, A. | +21

ErratumFor: Bone. 2022 Jul;160:116416. - PMID 35398293

39

Real-World Comparative Effectiveness and Safety of Tofacitinib and Baricitinib in Patients with Rheumatoid Arthritis

enthalten in: ResearchSquare.com | 2022

von Iwamoto, N. | Sato, S. | Kurushima, S. | +22

40

Randomized controlled trial of daily teriparatide, weekly high-dose teriparatide, or bisphosphonate in patients with postmenopausal osteoporosis : The TERABIT study

enthalten in: Bone | 2022

von Chiba, K. | Okazaki, N. | Kurogi, A. | +21

ErratumIn: Bone. 2022 Sep;162:116484. - PMID 35785593